Showing 12 of 54 posts with this tag
China’s colorectal cancer screening biotechnology company, New Horizon Health has completed a $30 million Series E funding led by healthcare hedge fund Rock Springs Capital, bringing its total funding to date to more than $160 million.
Source Code Capital announced on Tuesday that Zheng Yunduan has joined the company in the role of partner, as well as CHO in charge of organizational construction and related entrepreneurial services.
Source Code Capital officially released "Source Code Yisu" on Friday, operating the firm's seed-stage business independently within the investment system.
Hoosun, an intelligent device R&D firm, announced on July 12 that it had completed a round D of financing worth several hundred million yuan.
ByteDance's plan to launch a VC brand “Jinqiu Venture Capital” has been reportedly changed, and the brand name was no longer called “Jinqiu”.
Chinese synthetic biology firm Bluepha announced today that it has completed a B3 round of financing, bringing total round-B funds to 1.5 billion yuan ($235 million).
Last week saw one of the most prominent Chinese TMT investors Qiming Venture Partners raise their seventh USD fund, a notable milestone for a fund partly responsible for the success of companies like Xiaomi and Meituan Dianping.
In last week’s VC news, Chinese new retail cosmetics powerhouse HARMAY raised a considerable investment round, Sequoia Capital China launched a new infrastructure fund and more.
Several interesting news surfaced last week, with China’s VC industry getting back on its feet.
Sequoia Capital’s China affiliate has raised new funds totaling about $9 billion, to be used for investments in technology and healthcare. The firm received more than $12 billion in a 50% oversubscribed round.
Following reports that Chinese regulators are requiring domestic banks and some state-owned enterprises to check their exposure to Fosun and related enterprises, the private investment company responded on September 14 that the news is totally false.
Biotechnology startup MobiDrop completed an A+ round of financing worth nearly 100 million yuan ($14.8 million). The funding was led by LYFE Capital, followed by existing shareholder Source Code Capital and local government guidance entity Yunxiang Fund.